Controversial federal outline for ‘march-in’ rights on drugs has deep roots in California


Consumer advocates have long pushed for lower drug costs by opting to seize control of key patents.

Previous Aldevron to take over former Supervalu, Bluestem site in Eden Prairie
Next The Christ Hospital Health Network’s Precision Health program can personalize your health care approach